Document is current
Any future updates will be listed below
-
Authors
Jiang, Zhe
Ju, YoungJun
Ali, Amjad
Chung, Philip E. D. http://orcid.org/0000-0002-3443-3088
Skowron, Patryk
Wang, Dong-Yu http://orcid.org/0000-0002-5434-287X
Shrestha, Mariusz http://orcid.org/0009-0003-7880-7584
Li, Huiqin
Liu, Jeff C.
Vorobieva, Ioulia
Ghanbari-Azarnier, Ronak
Mwewa, Ethel http://orcid.org/0000-0003-0568-9372
Koritzinsky, Marianne
Ben-David, Yaacov http://orcid.org/0000-0002-9020-6074
Woodgett, James R. http://orcid.org/0000-0003-3731-5797
Perou, Charles M. http://orcid.org/0000-0001-9827-2247
Dupuy, Adam http://orcid.org/0000-0002-8561-4911
Bader, Gary D. http://orcid.org/0000-0003-0185-8861
Egan, Sean E. http://orcid.org/0000-0003-0189-3202
Taylor, Michael D. http://orcid.org/0000-0001-7009-3466
Zacksenhaus, Eldad http://orcid.org/0000-0001-6104-6094
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre
Terry Fox Foundation
Canadian Breast Cancer Foundation
DoD USA army
- License Information
-
More Information
Article History
Received: 22 June 2022
Accepted: 16 June 2023
First Online: 18 July 2023
Competing interests
: C.M.P. is an equity stockholder and consultant of BioClassifier LLC; C.M.P. is also listed as an inventor on patent applications for the Breast PAM50 Subtyping assay. There is no direct relationship between these PAM50 patents and the Intellectual Property and content of this study. The other authors declare no conflict of interest.
